Donald Small Jr., who has Parkinson's disease, will spend at least a couple of years in a prison for fatally stabbing his ...
The glucagon-like peptide-1 receptor agonist exenatide does not yield improvement in measures of Parkinson disease severity.
The US Food and Drug Administration has approved Onapgo (apomorphine hydrochloride) injection as the first and only subcutaneous apomorphine infusion device for the treatment of motor fluctuations in ...
Gene Mack, Gain Therapeutics CEO, provides a look into the future of the company and the use of physics-based artificial ...
Now, scientists in Korea have discovered that the Parkinson’s disease drug procyclidine can alleviate physical symptoms of ...
A woman who is at least the fourth generation of her family to suffer a "cruel" brain disorder, which leaves people trapped ...
Discover how MR-guided focused ultrasound offers a revolutionary non-invasive treatment for tremors and epilepsy reducing symptoms without surgery or implants ...
In December 2003, Osbourne was involved in an accident while riding his four-wheel all-terrain vehicle at his English estate.
2d
The Manual on MSNHow do brain chemicals affect your ability to stick to your fitness resolutions?Scientists point to a lack of certain brain chemicals as a key player when it comes to sticking to those fitness resolutions ...
13h
ThePrint on MSNNo incisions, no pain—AIIMS Delhi 1st govt hospital to treat neuro conditions with ultrasonic beamsMagnetic Resonance-guided Focused Ultrasound tech has the potential to treat conditions like essential tremors & Parkinson’s, ...
Acadia Pharmaceuticals' forecasted revenues top $1bn in 2025. Find out why ACAD stock is a "Buy" with its profitable outlook ...
Dr. Heh-In Im at the Center for Brain Disorders of the Korea Institute of Science and Technology (KIST) has identified a novel brain region and neural mechanism involved in regulating nicotine ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results